Viewing Study NCT01326728

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:11 AM
Ignite Modification Date: 2026-05-19 @ 2:15 PM
Study NCT ID: NCT01326728
Status: TERMINATED
Last Update Posted: 2018-06-06
First Post: 2011-03-30
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myelogenous Leukemia View
None Acute Myelogenous Leukemia View
None Acute Lymphoblastic Leukemia View
None Hodgkins Lymphoma View
None Non-Hodgkins Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapse View
None Hematologic Malignancy View
None Allogeneic View
None Hematopoietic Stem Cell Transplantation View
None Leukemia View
None Lymphoma View
None Hodgkin Lymphoma View